Need for a Heat-Stable Measles Vaccine for Use in West and Central Africa

Bernard Guyer; A. Marshal McBean; Albert E. Henn

doi:10.1056/NEJM197503062921017

Need for a Heat-Stable Measles Vaccine for Use in West and Central Africa

Bernard Guyer, A. Marshal McBean, Albert E. Henn

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Abstract

To the Editor: During the five years of the Smallpox Eradication and Measles Control Program (SMP) in West and Central Africa (1967–1971), 20 million children were vaccinated against measles at an estimated cost of $18 million to the United States alone. Yet, despite the use of an efficacious, live attenuated vaccine (Schwarz), measles was not controlled and continues to be one of the major causes of childhood mortality in this part of Africa.

Original language	English (US)
Number of pages	1
Journal	New England Journal of Medicine
Volume	292
Issue number	10
DOIs	https://doi.org/10.1056/NEJM197503062921017
State	Published - Mar 6 1975
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJM197503062921017

Cite this

@article{c02202f75c024d128b950aa4713d2e75,

title = "Need for a Heat-Stable Measles Vaccine for Use in West and Central Africa",

abstract = "To the Editor: During the five years of the Smallpox Eradication and Measles Control Program (SMP) in West and Central Africa (1967–1971), 20 million children were vaccinated against measles at an estimated cost of $18 million to the United States alone. Yet, despite the use of an efficacious, live attenuated vaccine (Schwarz), measles was not controlled and continues to be one of the major causes of childhood mortality in this part of Africa.",

author = "Bernard Guyer and McBean, {A. Marshal} and Henn, {Albert E.}",

year = "1975",

month = mar,

day = "6",

doi = "10.1056/NEJM197503062921017",

language = "English (US)",

volume = "292",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Need for a Heat-Stable Measles Vaccine for Use in West and Central Africa

AU - Guyer, Bernard

AU - McBean, A. Marshal

AU - Henn, Albert E.

PY - 1975/3/6

Y1 - 1975/3/6

N2 - To the Editor: During the five years of the Smallpox Eradication and Measles Control Program (SMP) in West and Central Africa (1967–1971), 20 million children were vaccinated against measles at an estimated cost of $18 million to the United States alone. Yet, despite the use of an efficacious, live attenuated vaccine (Schwarz), measles was not controlled and continues to be one of the major causes of childhood mortality in this part of Africa.

AB - To the Editor: During the five years of the Smallpox Eradication and Measles Control Program (SMP) in West and Central Africa (1967–1971), 20 million children were vaccinated against measles at an estimated cost of $18 million to the United States alone. Yet, despite the use of an efficacious, live attenuated vaccine (Schwarz), measles was not controlled and continues to be one of the major causes of childhood mortality in this part of Africa.

UR - http://www.scopus.com/inward/record.url?scp=0016844223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016844223&partnerID=8YFLogxK

U2 - 10.1056/NEJM197503062921017

DO - 10.1056/NEJM197503062921017

M3 - Letter

C2 - 1117900

AN - SCOPUS:0016844223

SN - 0028-4793

VL - 292

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -

Need for a Heat-Stable Measles Vaccine for Use in West and Central Africa

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this